Loading clinical trials...

The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice | Clinical Trials | Clareo Health

COMPLETEDNA

The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice

The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in Patients With Acute Lower Respiratory Tract Infections in Danish General Practice: A Pragmatic Randomised Controlled Trial

NCT06210282•Aalborg University

View on ClinicalTrials.gov

Summary

The goal of this randomised controlled trial is to determine if adults presenting with symptoms of an acute lower respiratory tract infection in general practice where the general practitioner suspects CAP, who have FLUS performed as an addition to usual care, have antibiotics prescribed less frequent compared to those given usual care only.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age ≥ 18 years.
•2. Acute cough (\< 21 days).
•3. At least one other symptom of acute lower respiratory tract infection (LRTI).
•4. The general practitioner suspects a bacterial community-acquired pneumonia.

Exclusion Criteria

•1. Previous antibiotic treatment for the current episode of acute LRTI.
•2. The patient is not listed with the general practitioner (no medical record available).
•3. The patient is not capable of understanding and signing informed consent.
•4. The patient does not wish to participate in the study.

Locations (1)

Center for General Practice at Aalborg University

Gistrup, Denmark

Key Dates

Start Date

November 3, 2023

Primary Completion Date

August 1, 2024

Completion Date

October 17, 2024

Last Updated

November 29, 2024

Enrollment

391

ACTUAL participants

Conditions

Lower Respiratory Tract InfectionCommunity Acquired Pneumonia

Interventions

Focused lung ultrasound (FLUS)

DIAGNOSTIC_TEST

Usual Care

OTHER

Respiratory Infections in Young Children

NCT07249996

Respiratory Tract Infections (RTI)Lower Respiratory Tract Infection (LRTI)+2 more

View study

COMPLETED

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

NCT07425561

PneumoniaPneumonia - Bacterial+6 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 29, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Effect of Focused Lung Ultrasonography on Antibiotic Prescribing in General Practice

Inclusion Criteria

Exclusion Criteria

Respiratory Infections in Young Children

Derivation and Validation of the Risk Evaluation Score for Pneumonia Involving Resistant Entities (RESPIRE)

Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and Acceptability Study

A Validation Study on a Prognostic Prediction Model for Respiratory Tract Infections

Targeting Vascular INflammation in Patients with Community-Acquired Pneumonia

Safe, Effective and Cost-Effective Oxygen Saturation Targets for Children and Adolescents With Respiratory Distress: a Randomized Controlled Trial